Consolidated Revenue (FY25)
$94.2B
▲ 8.4% YoY
Avg. Divisional EBITDA
24.6%
▲ 1.2 pts
R&D Allocation
$12.8B
▲ 14.1% YoY
Active Subsidiaries
400
▲ 28 new ventures
r>
Division / Subsidiary FY Revenue ($B) EBITDA Margin YoY Growth R&D Spend ($M) Strategic Tier Status
Aevum Energy & Power 18.4 28.2% +11.3% 2,140 Core Infrastructure Core
Zenth Digital Systems 24.1 31.5% +18.7% 4,850 High-Value Tech Core
Aevum Aerospace & Defense 12.8 22.4% +6.2% 3,200 Government Contract Growth
Zenth Health Sciences 14.2 26.8% +9.4% 2,900 Life Sciences Core
Aevum Capital Group 9.6 42.1% +5.8% 480 Wealth & Markets Core
Zenth Quantum Computing 1.4 -8.2% +142% 890 Emerging Tech Emerging
Aevum Fusion Research 0.3 -44.0% +210% 1,200 Deep Science Emerging
Zenth Orbital Manufacturing 0.9 -12.5% +85% 650 Space Economy Growth
Financial Filings & Reports View Archive →
  • 2025 Annual Report & 10-K Filing Published: Oct 15, 2025 · PDF, 12.4 MB
    ⬇ Download
  • Q3 2025 Earnings Release & Supplemental Published: Jul 28, 2025 · PDF, 8.1 MB
    ⬇ Download
  • Divisional ESG & Sustainability Breakdown Published: Jun 10, 2025 · PDF, 5.7 MB
    ⬇ Download
  • Chairman's Letter to Shareholders 2025 Published: May 22, 2025 · PDF, 2.3 MB
    ⬇ Download
Upcoming Investor Events
  • 12
    Nov
    Q4 2025 Earnings Call
    Webcast · 09:00 EST
  • 05
    Dec
    Annual Divisional Investor Day
    Neo Geneva HQ · Hybrid
  • 18
    Mar
    Annual General Meeting 2026
    London, UK · 14:00 GMT

Investor Relations

Contact: Aevum Zenth IR Dept.
Email: ir@aevumzenth.global
Phone: +41 22 700 0000
Hours: Mon-Fri, 08:00-17:00 CET
Mailing: Zenth Tower, Neo Geneva, 1201